Gena Heidary1, Sarah Mackinnon1, Alexandra Elliott1, Brenda J Barry2, Elizabeth C Engle3, David G Hunter4. 1. Department of Ophthalmology, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts. 2. Department of Neurology, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts; Howard Hughes Medical Institute, Chevy Chase, Maryland. 3. Department of Ophthalmology, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts; Department of Neurology, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts; F. M. Kirby Neurobiology Center, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts; Howard Hughes Medical Institute, Chevy Chase, Maryland. 4. Department of Ophthalmology, Boston Children's Hospital/Harvard Medical School, Boston, Massachusetts. Electronic address: david.hunter@childrens.harvard.edu.
Abstract
PURPOSE: To detail surgical strategy and strabismus outcomes in a genetically defined cohort of patients with congenital fibrosis of the extraocular muscles (CFEOM). METHODS: A total of 13 patients with genetically confirmed CFEOM (via genetic testing for mutations in KIF21A, PHOX2A, and TUBB3) were retrospectively identified after undergoing strabismus surgery at Boston Children's Hospital and surgical outcomes were compared. RESULTS: Age at first surgery ranged from 11 months to 63 years, with an average of 3 strabismus procedures per patient. Ten patients had CFEOM1, of whom 9 had the KIF21A R954W amino acid substitution and 1 had the M947T amino acid substitution. Of the 3 with CFEOM3, 2 had the TUBB3 E410K amino acid substitution, and 1 had a previously unreported E410V amino acid substitution. CFEOM1 patients all underwent at least 1 procedure to address chin-up posture. Chin-up posture improved from 24° ± 8° before surgery to 10.0° ± 8° postoperatively (P < 0.001). Three CFEOM1 patients developed exotropia after vertical muscle surgery alone; all had the R954W amino acid substitution. Postoperatively, 1 CFEOM1 patient developed a corneal ulcer. All CFEOM3 patients appeared to have underlying exposure keratopathy, successfully treated with prosthetic replacement of the ocular surface ecosystem (PROSE) lens in 2 patients. CONCLUSIONS: CFEOM is a complex strabismus disorder for which surgical management is difficult. Despite an aggressive surgical approach, multiple procedures may be necessary to achieve a desirable surgical effect. Knowledge of the underlying genetic diagnosis may help to inform surgical management.
PURPOSE: To detail surgical strategy and strabismus outcomes in a genetically defined cohort of patients with congenital fibrosis of the extraocular muscles (CFEOM). METHODS: A total of 13 patients with genetically confirmed CFEOM (via genetic testing for mutations in KIF21A, PHOX2A, and TUBB3) were retrospectively identified after undergoing strabismus surgery at Boston Children's Hospital and surgical outcomes were compared. RESULTS: Age at first surgery ranged from 11 months to 63 years, with an average of 3 strabismus procedures per patient. Ten patients had CFEOM1, of whom 9 had the KIF21A R954W amino acid substitution and 1 had the M947T amino acid substitution. Of the 3 with CFEOM3, 2 had the TUBB3 E410K amino acid substitution, and 1 had a previously unreported E410V amino acid substitution. CFEOM1 patients all underwent at least 1 procedure to address chin-up posture. Chin-up posture improved from 24° ± 8° before surgery to 10.0° ± 8° postoperatively (P < 0.001). Three CFEOM1 patients developed exotropia after vertical muscle surgery alone; all had the R954W amino acid substitution. Postoperatively, 1 CFEOM1 patient developed a corneal ulcer. All CFEOM3 patients appeared to have underlying exposure keratopathy, successfully treated with prosthetic replacement of the ocular surface ecosystem (PROSE) lens in 2 patients. CONCLUSIONS: CFEOM is a complex strabismus disorder for which surgical management is difficult. Despite an aggressive surgical approach, multiple procedures may be necessary to achieve a desirable surgical effect. Knowledge of the underlying genetic diagnosis may help to inform surgical management.
Authors: Federico G Velez; Neepa Thacker; Michelle T Britt; Deborah Alcorn; R Scott Foster; Arthur L Rosenbaum Journal: J AAPOS Date: 2004-10 Impact factor: 1.220
Authors: M Nakano; K Yamada; J Fain; E C Sener; C J Selleck; A H Awad; J Zwaan; P B Mullaney; T M Bosley; E C Engle Journal: Nat Genet Date: 2001-11 Impact factor: 38.330
Authors: Gustav Y Cederquist; Anna Luchniak; Max A Tischfield; Maya Peeva; Yuyu Song; Manoj P Menezes; Wai-Man Chan; Caroline Andrews; Sheena Chew; Robyn V Jamieson; Lavier Gomes; Maree Flaherty; Patricia Ellen Grant; Mohan L Gupta; Elizabeth C Engle Journal: Hum Mol Genet Date: 2012-09-21 Impact factor: 6.150
Authors: Koki Yamada; Wai-Man Chan; Caroline Andrews; Thomas M Bosley; Emin C Sener; Johan T Zwaan; Paul B Mullaney; Banu T Oztürk; A Nurten Akarsu; Louise J Sabol; Joseph L Demer; Timothy J Sullivan; Irene Gottlob; Peter Roggenkäemper; David A Mackey; Clara E De Uzcategui; Nicolas Uzcategui; Bruria Ben-Zeev; Elias I Traboulsi; Adriano Magli; Teresa de Berardinis; Vincenzo Gagliardi; Sudha Awasthi-Patney; Marlene C Vogel; Joseph F Rizzo; Elizabeth C Engle Journal: Invest Ophthalmol Vis Sci Date: 2004-07 Impact factor: 4.799